相关实验视频

Updated: Aug 9, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

高脂肪饮食的持续时间对大细胞过度增生在老鼠的流行病的影响

Zhaoxin Wang¹, Xiujuan Liu¹, Lei Sheng²

¹Department of Sports and Health, Nanjing Sport Institute, Nanjing, China.

Obesity research & clinical practice

|February 8, 2025

概括

高脂肪饮食 (HFD) 根据持续时间对脂肪细胞增生有不同的影响. 八周的HFD增强了增多症,而12周减少了它,这表明饮食持续时间对肥胖研究至关重要.

科学领域:

代谢研究的研究.
肥胖研究的研究.
脂肪细胞生物学脂肪细胞生物学

背景情况:

高脂肪饮食 (HFD) 与肥胖和改变的脂肪细胞标志物有关.
HFD持续时间对脂肪细胞激增的影响尚未得到充分证实.
这项研究调查了HFD持续时间对脂肪细胞增生和成熟标志物的影响.

研究的目的:

为了确定不同持续时间的HFD如何影响脂肪细胞增生.
在不同的HFD持续时间下分析成熟脂肪细胞标记物的表达.
了解饮食持续时间在HFD引起的肥胖症中的作用.

主要方法:

32只斯普拉格-道利大鼠被分为对照组和HFD组 (4,8,12周).
评估了流行性脂肪形态,血清炎症标志物 (ELISA) 和脂肪细胞标志物 (西部斑).
关键标志物包括勒素,TNF-α,IL-6,虹膜素,PPARγ,阿迪波内克丁,FNDC5,里平A和ATGL.

主要成果:

在长达8周的时间里,HFD增加了体重,脂肪重量以及勒素,TNF-α,IL-6,虹膜素,PPARγ,阿迪波内克丁和FNDC5等标记物.
12周的HFD导致虹膜素,PPARγ,阿迪波内克丁和FNDC5.5的减少.
长时间的HFD (12周) 也降低了利平A和ATGL的表达.

结论:

饮食持续时间极大地影响HFD诱导的肥胖症中的脂肪细胞增生.
八周的HFD促进了脂肪细胞增生.
延长HFD (12周) 减少了脂肪细胞增生能力.

关键词:

脂肪细胞过度增生症亚迪波尼克丁氨酸是什么肥胖过程肥胖过程在PPARγ中,PPARγ是PPARγ 利蛋白-A 是一种

更多相关视频

High Fat Diet Feeding and High Throughput Triacylglyceride Assay in Drosophila Melanogaster

High Fat Diet Feeding and High Throughput Triacylglyceride Assay in Drosophila Melanogaster

Published on: September 13, 2017

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

相关概念视频

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Hyperglycemia

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...